France Ultrasound Devices Market Size

France Ultrasound Devices Market Analysis

The France Ultrasound Devices Market size is estimated at USD 475.14 million in 2024, and is expected to reach USD 623.35 million by 2029, growing at a CAGR of 5.58% during the forecast period (2024-2029).

The pandemic had an adverse effect on the ultrasound devices market in the country. Additionally, the well-known for its effectiveness French healthcare system was put under a great deal of stress in the early phases of the pandemic. Portable ultrasound machines are essential in the fight against the COVID-19 pandemic, according to a research paper that appeared in the Springer Journal in February 2020. In France, intensive care physicians use point-of-care ultrasounds, typically with small transportable ultrasound devices, for bedside imaging, and in the ICU. Although there was a decrease in the overall number of ultrasounds in private centers as a result of COVID-19, this was because 52.8% of the radiologic structures followed the French recommendations to dedicate devices to COVID-19, which led to fewer ultrasound devices and more COVID-19 patients, which in turn limited access for other pathologies. According to the article "Effect of the COVID-19 Pandemic on Colorectal Cancer Care in France" published in the Lancet magazine in May 2021, researchers found a 31% decrease in new referrals for colorectal cancer in 2020 (March to May) compared to the average of the preceding two years. On the other hand, the epidemic has moved attention away from cancer treatment. Because fewer people were screened within the nation as a result, fewer ultrasound scans were performed nationwide. Thus, the market had an adverse effect during the pandemic however, it is expected to grow as pending cases will boost the market in the upcoming period.

The ultrasound market in France is expected to grow during the study's forecast period due to the rising prevalence of chronic diseases such as cardiovascular diseases, as well as technical advances in the country. For instance, according to a report titled "Heart Failure Policy and Practice in Europe: France" that was released in November 2020, heart failure is predicted to impact approximately one million people in France or 2.3% of the country's total population. Heart attacks are significantly increased by coronary artery disease and other cardiovascular disease risk factors like diabetes and hypertension. Ultrasound imaging devices are one of the most crucial diagnostic imaging systems for the diagnosis of a variety of cardiovascular abnormalities, including coronary artery disease. Major players are engaged in a variety of strategic activities. These include of product launches, collaborations, partnerships, mergers, and acquisitions. For instance, to speed up the development of AI in medical imaging, the AI DReAM initiative, coordinated by GE Healthcare, will bring together French SMEs, start-ups, research labs, and clinical centers in September 2020. The "Investments for the Future" program (PIA), which is run by Bpifrance and is overseen by the French General Secretariat for Investment, provided funding for the AI DReAM project. It strives to increase the effectiveness of the healthcare system, patient care pathways, and diagnosis accuracy. Thus, the abovementioned factors are expected to increase market growth.